Search results for "Peyronie's disease"

showing 10 items of 14 documents

Smoking, diabetes, blood hypertension: possible etiologic role for Peyronie’s disease? Analysis in 279 patients with a control group in Sicily

2015

Objective: To assess the proportion of patients with Peyronie’s Disease (PD) and the possible association with its potential risk factors in the general population of the central and western Sicily in our weekly andrological outpatient clinic. Materials and methods: We recruited a sample of 279 consecutive patients consulting our andrological outpatient clinic. Two arms were created: the first one composed by PD patients (men with symptoms suggestive for PD), the second one composed by patients with other andrological diseases (control arm). For each patient we evaluated the age, cigarette smoking, diabetes, blood hypertension and erectile function. In the PD arm we administered validated q…

AdultMalemedicine.medical_specialtyVisual analogue scalePeyronie's diseaseUrologyPenile IndurationPopulationPainDiabetelcsh:RC870-923Severity of Illness IndexSettore MED/24 - UrologiaDiabetes ComplicationsAgeRisk FactorsCigarette smokingSurveys and QuestionnairesInternal medicineDiabetes mellitusPrevalencePeyronie’s diseasemedicineHumansOutpatient clinicErectile dysfunctionRisk factoreducationSicilyAgededucation.field_of_studyUnivariate analysisbusiness.industrySmokingDiabetesMiddle Agedlcsh:Diseases of the genitourinary system. Urologymedicine.diseaseSurgeryErectile dysfunctionBlood hypertensionCase-Control StudiesHypertensionPeyronie's diseasebusinessArchivio Italiano di Urologia e Andrologia
researchProduct

The role of intrinsic pathway in apoptosis activation and progression in Peyronie's Disease.

2014

Peyronie’s disease (PD) is characterized with formation of fibrous plaques which result in penile deformity, pain, and erectile dysfunction. The aim of this study was to investigate the activation of the intrinsic apoptotic pathway in plaques from PD patients. Tunica albuginea from either PD or control patients was assessed for the expression of bax, bcl-2 and caspases 9 and 3 using immunohistochemistry and by measurement of apoptotic cells using TUNEL assay. Bax overexpression was observed in metaplastic bone tissue, in fibroblasts, and in myofibroblast of plaques from PD patients. Little or no bcl-2 immunostaining was detected in samples from either patients or controls. Caspase 3 immunos…

AdultMalePathologymedicine.medical_specialtyArticle SubjectPenile Indurationlcsh:MedicineCaspase 3Apoptosisapoptosis peironie's disease urethraBone tissueGeneral Biochemistry Genetics and Molecular BiologySettore MED/24 - UrologiaYoung AdultBcl-2-associated X proteinPeyronie’s diseasemedicineIn Situ Nick-End LabelingHumansCaspaseAgedbcl-2-Associated X ProteinGeneral Immunology and MicrobiologybiologyStaining and LabelingOssificationCaspase 3Settore BIO/16 - Anatomia Umanalcsh:RGeneral MedicineMiddle Agedmedicine.diseaseImmunohistochemistryCaspase 9medicine.anatomical_structurePeyronie’s disease. ; Apoptosis; Immunohistochemistrybiology.proteinDisease Progressionmedicine.symptomPeyronie's diseaseMyofibroblastImmunostainingSignal TransductionResearch Article
researchProduct

Cytokines gene expression in the tunica albuginea in patients with Peyronie’s disease. Pilot study with a control group

2011

INTRODUCTION: We decided to conduct a study to investigate the presence of cytokines in the albuginea of subjects with Peyronie's disease (PD). Cytokines, as responsible for intercellular communication, maybe involved in the pathogenesis of the disease. The identification of one or more involved cytokines may, in fact, be useful in the pharmacological treatment with biologic drugs that are able to interfere with specific cytokines. MATERIALS AND METHODS: Between January 2009 and Decembre 2010 at the Clinic of Urological outpatients clinic of the Policlinico of Palermo were recruited 20 subjects with PD, mean age 62.3 years (range 51-70) and 8 subjects with congenital recurvatum penis (mean …

cytokines Induratio Penis Plastica Peyronie's disease Gene expression Tunica albuginea Biologic drugsSettore MED/24 - Urologia
researchProduct

Does Transfer Capacitive Resistive Energy Has a Therapeutic Effect on Peyronie's Disease? Randomized, Single-Blind, Sham-Controlled Study on 96 Patie…

2017

<b><i>Background/Aims/Objectives:</i></b> We have investigated the clinical and physiological effects of Transfer Capacitive Resistive Energy (TCARE) therapy on men with Peyronie's disease (PD). <b><i>Methods:</i></b> Ninety-six men with PD have been randomized in a 2:1 ratio to receive 3 sessions of TCARE therapy or sham therapy. Pain, penile curvature and erectile function have been assessed before the first treatment and up to 9 months after the end of treatment, using the Visual Analogue Scale for the pain, a goniometer to measure the degree of curvature using at-home photography and an International Index of Erectile Function (IIEF-5) que…

Malemedicine.medical_specialtyTime FactorsVisual analogue scalePeyronie's diseaseUrologyPenile Induration030232 urology & nephrologyPain reliefPainElectric Stimulation TherapyElectric Capacitance03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesElectric ImpedanceMedicineHumansSingle-Blind MethodAdverse effectPenile painAgedPain MeasurementResistive touchscreenErectile failure; Induratio penis plastic; Penile pain; Penis plaque; Peyronie's disease; Transfer capacitive resistive energy; Urology030219 obstetrics & reproductive medicinebusiness.industrySettore MED/34 - Medicina Fisica E RiabilitativaPenile ErectionInduratio penis plasticTransfer capacitive resistive energyTherapeutic effectRecovery of FunctionMiddle Agedmedicine.diseaseTreatment OutcomeTolerabilityItalyPhysical therapyPenile painPeyronie's diseasebusinessErectile failurePenis plaquePenisUrologia internationalis
researchProduct

SAFETY AND TOLERABILITY OF LOCAL TREATMENT WITH ILOPROST, A PROSTACYCLIN ANALOGUE, IN PATIENTS WITH PEYRONIE'S DISEASE. A PHASE I STUDY

2011

Objective. To assess the possibility of intralesional therapy for the treatment of Peyronie's disease, we have verified the safety and tolerability of intralesional injections of Iloprost ( an I 2 Prostacyclin analogue) for its property to suppress the production of CTFG in fibroblasts. CTFG is a connective tissue growth factor that acts in concert with TGF-β to stimulate the fibrotic process. Materials and methods. 38 patients with Peyronie’s disease were preliminarily evaluated by considering the symptoms, the degree of penile curvature, and the size of the plaque. Each patient received weekly intralesional injections of 200 ng of Iloprost in 1 ml normal saline for 5 weeks. If tolerated, …

PEYRONIE'S DISEASE ILOPROST INTRALESIONAL THERAPY NON SURGICAL THERAPYSettore MED/24 - Urologia
researchProduct

Commentary on “Effects of patients' understanding and choice of surgical types on postoperative outcomes of Peyronie's disease: a single-center retro…

2021

Surgical correction can be considered for treating patients with a chronic phase of Peyronie's disease (PD) and persistent penile curvature. In clinical practice, some patients pay too much attention to surgical complications and refuse the recommended feasible surgical types. Meanwhile, they require operations according to their preferences. This study aimed to evaluate the effects of patients’ own choice of surgical type on postoperative satisfaction. This retrospective study analyzed data from 108 patients with PD who underwent surgical correction according to doctors’ recommendations or patients’ own demands. The objective and subjective surgical outcomes were assessed. Patients’ unders…

Malemedicine.medical_specialtygrafting procedurePeyronie's diseaseUrologyPenile IndurationSingle CenterErectile Dysfunctionpatient's satisfactionmedicineHumansPostoperative Periodpenile curvatureRetrospective Studiesbusiness.industryRetrospective cohort studyGeneral Medicinemedicine.diseaseDiseases of the genitourinary system. UrologySurgeryCommentaryplicationOriginal ArticleRC870-923Peyronie's diseasebusinessPenisAsian Journal of Andrology
researchProduct

Cytokines gene expression in the tunica albuginea of patients with Peyronie’s disease. Pilot study with a control group

2012

INTRODUCTION & OBJECTIVES: Cytokines may be involved in the pathogenesis of the Peyronie's disease (PD). Cytokines levels in tunica albuginea (TA) specimens were measured by Real Time PCR in PD patients and in control group. MATERIAL & METHODS: Between January 2009 and December 2010 20 PD patients affected by PD and 8 patients affected by congenital recurvatum penis (control group) undergoing surgery were entered in the study. Routine histological examination and measurement by Real Time PCR of the expression of the encoding genes for IL-2, IL-4, IL-6, IL-10, IL-13, TGF-β1, TNF-α, IFN-γ and Metalloproteinase (MMP-2) were performed. For the normalization of data, GAPDH (glucerldehyde-3 fosfa…

Cytokines gene expressionPeyronie's diseaseSettore MED/24 - Urologia
researchProduct

Cytokine gene expression in the tunica albuginea of patients with Peyronie's disease. Pilot study with a control group.

2012

Introduction and objective Cytokines may be involved in the pathogenesis of Peyronie's disease (PD). In this case, biological drugs, acting on specific cytokines, could be adopted in the pharmacological treatment of the disease. Materials and Methods Twenty PD patients and 8 patients affected by congenital recurvatum penis (control group) who underwent corporoplasty were enrolled in the study Histological examination and measurement by Real Time PCR of the expression of the encoding genes for IL-2, IL-4, IL-6, IL-10, IL-13, TGF-β, TNF-α and IFN-γ were performed on the removed tunica albuginea (TA). For the normalization of data GAPDH (glucerldehyde-3fosfatehydrogenase) and GUSB (β-glucuroni…

MalePathologymedicine.medical_specialtymedicine.medical_treatmentPenile IndurationGene ExpressionInflammationPilot ProjectsSettore MED/24 - UrologiaPathogenesisTunica albuginea (ovaries)Young AdultCytokines Induratio Penis Plastica PEYRONIE's disease gene expression Tunica albuginea Biological drugsMedicineHumansbusiness.industryGeneral Medicinemedicine.diseaseHousekeeping genemedicine.anatomical_structureCytokineReal-time polymerase chain reactionCavernous tissueCytokinesPeyronie's diseasemedicine.symptombusinessPenis
researchProduct

Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study

2011

medicine.medical_specialtybusiness.industryUrologyMEDLINEProstacyclinmedicine.diseaseSurgeryPhase i studyClinical trialTolerabilityInternal medicineMedicineIn patientPeyronie's diseasebusinessIloprostmedicine.drugBJU International
researchProduct

Peyronie’s disease: Cytokines genes expression in tunica albuginea

2012

Peyronie's disease cytokinesSettore MED/24 - Urologia
researchProduct